Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres

Phytomedicine

Volumn 22, Issue 4, 2015, Pages 438-443

  Seo, Ean Jeong ^a   Wiench, Benjamin ^a   Hamm, Rebecca ^a   Paulsen, Malte ^b   Zu, Yuangang ^c   Fu, Yujie ^c   Efferth, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^c NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Artesunate; Cajanin stilbene acid (CSA); Cancer stem like cells; Drug resistance; Mammospheres; Shikonin

Indexed keywords

ANTINEOPLASTIC AGENT; ARTESUNATE; CAJANIN; CD24 ANTIGEN; CD44V ANTIGEN; DOCETAXEL; FLUOROURACIL; NATURAL PRODUCT; PLANT MEDICINAL PRODUCT; SHIKONIN; STILBENE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER STEM CELL; COLLATERAL CIRCULATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC50; MCF 7 CELL LINE; MONOLAYER CULTURE; NEOPLASM; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RESAZURIN ASSAY; SURVIVAL TIME;

EID: 84964292845     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.01.012     Document Type: Article

References (28)

1. Aguirre-Ghiso J.A. Models, mechanisms and clinical evidence for cancer dormancy Nat. Rev. Cancer 7 2007 834 846
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
3. Borovski T., De Sousa E., Melo F., Vermeulen L., Medema J.P. Cancer stem cell niche: the place to be Cancer Res. 71 2011 634 639
4. Brown J.M., Giaccia A.J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy Cancer Res. 58 1998 1408 1416
5. Brown J.M., Wilson W.R. Exploiting tumour hypoxia in cancer treatment Nat. Rev. Cancer 4 2004 437 447
6. Calcagno A.M., Salcido C.D., Gillet J.P., Wu C.P., Fostel J.M., Mumau M.D., Gottesman M.M., Varticovski L., Ambudkar S.V. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics J. Natl. Cancer Inst. 102 2010 1637 1652
7. Cioce M., Gherardi S., Viglietto G., Strano S., Blandino G., Muti P., Ciliberto G. Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs Cell Cycle 9 2010 2878 2887
8. Clevers H. The cancer stem cell: premises, promises and challenges Nat. Med. 17 2011 313 319
9. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance Nat. Rev. Cancer 5 2005 275 284
10. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev. 17 2003 1253 1270
11. Efferth T. Cancer therapy with natural products and medicinal plants Planta Med. 76 2010 1035 1036
12. Efferth T. Stem cells, cancer stem-like cells, and natural products Planta Med. 78 2012 935 942
13. Green S.K., Frankel A., Kerbel R.S. Adhesion-dependent multicellular drug resistance Anti-cancer Drug Des. 14 1999 153 168
14. Guttilla I.K., Phoenix K.N., Hong X., Tirnauer J.S., Claffey K.P., White B.A. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs Breast Cancer Res. Treat. 132 2012 75 85
15. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323
16. Laberge R.M., Ambadipudi R., Georges E. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil Arch. Biochem. Biophys. 491 2009 53 60
17. Laberge R.M., Ambadipudi R., Georges E. P-glycoprotein mediates the collateral sensitivity of multidrug resistant cells to steroid hormones Biochem. Biophys. Res. Commun. 447 2014 574 579
18. Li X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M.F., Hilsenbeck S.G., Pavlick A., Zhang X., Chamness G.C., Wong H., Rosen J., Chang J.C. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J. Natl. Cancer Inst. 100 2008 672 679
19. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
20. Patel P., Chen E.I. Cancer stem cells, tumor dormancy, and metastasis Front. Endocrinol. (Lausanne, Switz.) 3 2012 125
21. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res. 65 2005 5506 5511
22. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
23. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
24. Schabath H., Runz S., Joumaa S., Altevogt P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells J. Cell Sci. 119 2006 314 325
25. Sengupta A., Cancelas J.A. Cancer stem cells: a stride towards cancer cure? J. Cell. Physiol. 225 2010 7 14
26. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells Nature 432 2004 396 401
27. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches Nat. Rev. Immunol. 6 2006 93 106
28. Zhou B.B., Zhang H., Damelin M., Geles K.G., Grindley J.C., Dirks P.B. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Nat. Rev. Drug Discov. 8 2009 806 823